Artisan Partners Limited Partnership Neurocrine Biosciences Inc Transaction History

Artisan Partners Limited Partnership

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$86.8 - $118.57 $25.2 Million - $34.4 Million	-289,942 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$83.82 - $101.5 $1.24 Million - $1.5 Million	14,745 Added 5.36%	289,942 $26.1 Million
Q2 2019 Aug 09, 2019	SELL	$72.24 - $91.27 $517,021 - $653,219	-7,157 Reduced 2.53%	275,197 $23.2 Million
Q1 2019 May 10, 2019	SELL	$69.31 - $91.53 $96.3 Million - $127 Million	-1,389,833 Reduced 83.11%	282,354 $24.9 Million
Q4 2018 Feb 12, 2019	SELL	$68.32 - $124.36 $11.3 Million - $20.5 Million	-165,077 Reduced 8.98%	1,672,187 $119 Million
Q3 2018 Nov 13, 2018	SELL	$98.88 - $125.85 $3.99 Million - $5.08 Million	-40,381 Reduced 2.15%	1,837,264 $226 Million
Q2 2018 Aug 10, 2018	SELL	$75.3 - $105.99 $6.66 Million - $9.38 Million	-88,464 Reduced 4.5%	1,877,645 $184 Million
Q1 2018 May 10, 2018	BUY	$75.88 - $92.43 $49.9 Million - $60.8 Million	657,712 Added 50.27%	1,966,109 $163 Million
Q4 2017 Feb 12, 2018	BUY	$58.53 - $77.59 $56.7 Million - $75.2 Million	968,957 Added 285.46%	1,308,397 $102 Million
Q3 2017 Nov 13, 2017	BUY	$47.97 - $61.28 $16.3 Million - $20.8 Million	339,440	339,440 $20.8 Million

638

93.8M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.